The use of isoprinosine in patients with amyotrophic lateral sclerosis.
D000081:Acetamides / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000605:Amino Alcohols / Q000627:therapeutic use*; D000690:Amyotrophic Lateral Sclerosis / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology; D001565:Benzoates / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003402:Creatine Kinase / Q000032:analysis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008168:Lung / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009705:Nucleosides / Q000627:therapeutic use*; D010919:Placebos; D013060:Speech; D014527:Uric Acid / Q000097:blood
D000081:Acetamides; D000605:Amino Alcohols; D001565:Benzoates; D009705:Nucleosides; D010919:Placebos; D014527:Uric Acid; D003402:Creatine Kinase